Effect of complexation of 3-aminoquinoxaline-2-carbonitrile 1,4-dioxides with palladium and copper on their anti-T. cruzi activity

Medicinal Chemistry Research

Volumn 21, Issue 7, 2012, Pages 1439-1444

  Benítez, Diego ^a   Lavaggi, María L ^a   Gambino, Dinorah ^b   Torre, María H ^b   Cerecetto, Hugo ^a   González, Mercedes ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

3 Aminoquinoxaline 2 carbonitrile 1; 4 dioxide; Chagas disease; Copper complexes; Palladium complexes; Trypanosoma cruzi

Indexed keywords

3 AMINOQUINOXALINE 2 CARBONITRILE 1,4 DIOXIDE DERIVATIVE; ANTIPROTOZOAL AGENT; COPPER COMPLEX; PALLADIUM COMPLEX; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; COMPLEX FORMATION; IN VITRO STUDY; NONHUMAN; TRYPANOSOMA CRUZI;

EID: 84861908967     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9660-y     Document Type: Article

References (26)

1. Aguirre G, Cerecetto H, Di Maio R, González M, Montoya Alfaro ME, Jaso A, Zarranz B, Ortega MA, Aldana I, Monge-Vega A (2004) Quinoxaline N, N′-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi structure- activity relationships. Bioorg Med Chem Lett 14: 3835-3839
2. Ancizu S, Moreno E, Torres E, Burguete A, Pérez-Silanes S, Benítez D, Villar R, Solano B, Marín A, Aldana I, Cerecetto H, González M, Monge A (2009) Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs. Molecules 14:2256-2272
3. Castro JA, de Meca MM, Bartel LC (2006) Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum Exp Toxicol 25:471-479
4. Cavalli A, Bolognesi ML (2009) Neglected tropical diseases: multitarget- directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania. J Med Chem 52: 7339-7359
5. Cerecetto H, González M (2007) Benzofuroxan and Furoxan. Chemistry and biology. In: Khan MTH (ed) Topics in heterocyclic chemistry. Bioactive heterocycles V, vol 10. Springer, Berlin
6. Cerecetto H, González M (2010) Synthetic medicinal chemistry in Chagas' disease: compounds at the final stage of "Hit-to-Lead" phase. Pharmaceuticals 2. doi:10.3390/ph20x000x
7. Geary WJ (1971) The use of conductivity measurements in organic solvents for the characterisation of coordination compounds. Coord Chem Rev 7:81-122
8. González M, Cerecetto H, Monge A (2007) Quinoxaline 1,4-dioxide and phenazine 5,10-dioxide. Chemistry and biology. In: Khan MTH (ed) Topics in Heterocyclic Chemistry. Bioactive heteroccyles V, vol.11 Springer, Berlin
9. Lever ABP (1984) Inorganic electronic spectroscopy. Elsevier, Amsterdam
10. Nwaka S, Ridley RG (2003) Virtual drug discovery and development for neglected diseases through public-private partnerships. Nat Rev Drug Disc 2:919-928
11. Otero L, Vieites M, Boiani L, Denicola A, Rigol C, Opazo L, Olea-Azar C, Maya JD, Morello A, Krauth-Siegel RL, Piro OE, Castellano E, González M, Gambino D, Cerecetto H (2006a) Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets. J Med Chem 49:3322-3331
12. Otero L, Aguirre G, Boiani L, Denicola A, Rigol C, Olea-Azar C, Maya JD, Morello A, González M, Gambino D, Cerecetto H (2006b) Nitrofurylsemicarbazone rhenium and ruthenium complexes as anti-trypanosomal agents. Eur J Med Chem 41:1231-1239
13. Rivera G, Bocanegra-García V, Ordaz-Pichardo C, Nogueda-Torres B, Monge A (2009) New therapeutic targets for drug design against Trypanosoma cruzi, advances and perspectives. Curr Med Chem 16:3286-3293
14. Rodrigues Coura J, Castro SL (2002) A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97:3-24
15. Schofield CJ, Jannin J, Salvatella R (2006) The future of Chagas disease control. Trends Parasitol 22:583-588
16. Stoll S, Schweiger A (2006) EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J Magn Reson 178:42-55
17. Tarallo MB, Costa-Filho AJ, Vieira ED, Monge A, Leite CQ, Pavan FR, Borthagaray G, Gambino D, Torre MH (2009) Research of new mixed-chelate copper complexes with quinoxaline N1, N4-dioxide derivatives and alanine as ligands, potential antimycobacterial agents. J Argentine Chem Soc 97:80-89
18. Torre MH, Gambino D, Araujo J, Cerecetto H, González M, Lavaggi ML, Azqueta A, López de Cerain A, Monge Vega A, Abram U, Costa-Filho AJ (2005) Novel Cu(II) Quinoxaline N1, N4-dioxide complexes as selective hypoxic cytotoxins. Eur J Med Chem 40(5):473-480
19. Urquiola C, Vieites M, Aguirre G, Marín A, Solano B, Arrambide G, Noblía P, Lavaggi ML, Torre MH, González M, Monge A, Gambino D, Cerecetto H (2006) Improving anti-trypanosomal activity of 3-aminoquinoxaline-2- carbonitrile N1, N4-dioxide derivatives by complexation with vanadium. Bioorg Med Chem 15:5503-5509
20. Urquiola C, Gambino D, Cabrera M, Lavaggi ML, Cerecetto H, González M, López de Ceráin A, Monge A, Costa-Filho AJ, Torre MH (2008) New copper-based complexes with quinoxaline N(1), N(4)-dioxide derivatives, potential antitumoral agents. J Inorg Biochem 102:119-126
21. Urquiola C, Vieites M, Torre MH, Cabrera M, Lavaggi L, Cerecetto H, González M, López de Ceráin A, Monge A, Smircich P, Garat B, Gambino D (2009) Cytotoxic palladium complexes of bioreductive quinoxaline N1, N4-dioxide prodrugs. Bioorg Med Chem 17:1623-1629
22. Vieites M, Otero L, Santos D, Toloza J, Figueroa R, Norambuena E, Olea-Azar C, Aguirre G, Cerecetto H, González M, Morello A, Maya JD, Garat B, Gambino D (2008a) Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents. J Inorg Biochem 102:1033-1043
23. Vieites M, Smircich P, Parajon-Costa B, Rodríguez J, Galaz V, Olea-Azar C, Otero L, Aguirre G, Cerecetto H, González M, Gómez-Barrio A, Garat B, Gambino D (2008b) Potent in vitro anti-Trypanosoma cruzi activity of pyridine-2-thiol N-oxide metal complexes having an inhibitory effect on parasite-specific fumarate reductase. J Biol Inorg Chem 13:723-735
24. Vieites M, Otero L, Santos D, Olea-Azar C, Norambuena E, Aguirre G, Cerecetto H, González M, Kemmerling U, Morello A, Maya DJ, Gambino D (2009) Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity. J Inorg Biochem 103:411-418
25. Zamalloa E, Aldana I, Bachiller CM, Monge A (1997a) Physicochemical properties and stability of the new hypoxia-selective agent 7-chloro-3-[[N,N- dimethylamino)propyl]amino]-2-quinoxalinecarbonitrile 1,4-di-N-oxide hydrochloride. Arzneimittelforsch 47:873-878
26. Zamalloa E, Dios-Viéitez C, González-Peña E, Monge A (1997b) Determination of a new hypoxia selective agent from 2- quinoxalinecarbonitrile 1,4-di-N-oxides in plasma by high performance liquid chromatography. Arzneimittelforsch 47:1044-1046